151 related articles for article (PubMed ID: 32882204)
1. Autoimmune hematologic complications of umbilical cord blood transplantation.
Ibrahim U; Keyzner A
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):104-109. PubMed ID: 32882204
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
Chao MM; Levine JE; Ferrara JL; Cooling L; Cooke KR; Hutchinson RJ; Yanik GA
Pediatr Blood Cancer; 2008 Apr; 50(4):917-9. PubMed ID: 17417790
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.
Page KM; Mendizabal AM; Prasad VK; Martin PL; Parikh S; Wood S; Sempowski GD; Szabolcs P; Kurtzberg J
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1108-1117. PubMed ID: 18804040
[TBL] [Abstract][Full Text] [Related]
4. CAMPATH-1H in the treatment of autoimmune cytopenias.
Marsh JC; Gordon-Smith EC
Cytotherapy; 2001; 3(3):189-95. PubMed ID: 12171725
[TBL] [Abstract][Full Text] [Related]
5. [Exacerbation of autoimmune neutropenia to agranulocytosis in association with severe autoimmune thrombocytopenia and hemolytic anemia in a patient with Sjögren's syndrome].
Shimoji S; Takiuchi Y; Maruoka H; Inoue D; Kimura T; Mori M; Nagai Y; Togami K; Tabata S; Kurata M; Matsushita A; Nagai K; Takahashi T
Rinsho Ketsueki; 2011 Jul; 52(7):535-9. PubMed ID: 21821986
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature.
Neunert CE; Despotovic JM
Pediatr Blood Cancer; 2019 Apr; 66(4):e27569. PubMed ID: 30537439
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders.
Lim SH; Ifthikharuddin JJ
Leuk Lymphoma; 1994 Sep; 15(1-2):61-4. PubMed ID: 7858503
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune thrombocytopenia, neutropenia and hemolysis].
Greinacher A; Bux J; Salama A
Internist (Berl); 2009 Mar; 50(3):276-90. PubMed ID: 19225748
[TBL] [Abstract][Full Text] [Related]
9. Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients.
Elimelakh M; Dayton V; Park KS; Gruessner AC; Sutherland D; Howe RB; Reding MT; Eastlund T; van Burik JA; Singleton TP; Gruessner RW; Key NS
Haematologica; 2007 Aug; 92(8):1029-36. PubMed ID: 17640860
[TBL] [Abstract][Full Text] [Related]
10. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
11. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
12. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.
Taherifard E; Taherifard E; Movahed H; Mousavi MR
Hematology; 2021 Dec; 26(1):225-239. PubMed ID: 33594951
[TBL] [Abstract][Full Text] [Related]
13. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
14. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children.
Kim TO; Despotovic JM
Hematol Oncol Clin North Am; 2019 Jun; 33(3):489-506. PubMed ID: 31030815
[TBL] [Abstract][Full Text] [Related]
15. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.
Bhatt V; Shune L; Lauer E; Lubin M; Devlin SM; Scaradavou A; Parameswaran R; Perales MA; Ponce DM; Mantha S; Kernan NA; Barker JN
Bone Marrow Transplant; 2016 Dec; 51(12):1579-1583. PubMed ID: 27643868
[TBL] [Abstract][Full Text] [Related]
17. B cell-targeted therapy in diseases other than rheumatoid arthritis.
Looney RJ
J Rheumatol Suppl; 2005 Feb; 73():25-8; discussion 29-30. PubMed ID: 15693113
[TBL] [Abstract][Full Text] [Related]
18. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.
Newman K; Owlia MB; El-Hemaidi I; Akhtari M
Autoimmun Rev; 2013 May; 12(7):784-91. PubMed ID: 23462431
[TBL] [Abstract][Full Text] [Related]
19. Development of common variable immunodeficiency in a patient with Evans syndrome treated by autologous stem cell transplantation.
Starý J; Sedlácek P; Vodvárková S; Gasová Z; Bartůnková J
Pediatr Allergy Immunol; 2003 Aug; 14(4):334-7. PubMed ID: 12911516
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe Evans syndrome with an allogeneic cord blood transplant.
Raetz E; Beatty PG; Adams RH
Bone Marrow Transplant; 1997 Sep; 20(5):427-9. PubMed ID: 9339762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
